BiotechTube

Lecanemab IV + Placebo + Lecanemab SC

Phase 3Active
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Early Alzheimer's Disease

Conditions

Early Alzheimer's Disease

Trial Timeline

Mar 27, 2019 โ†’ Jun 30, 2029

NCT ID
NCT03887455

About Lecanemab IV + Placebo + Lecanemab SC

Lecanemab IV + Placebo + Lecanemab SC is a phase 3 stage product being developed by Eisai for Early Alzheimer's Disease. The current trial status is active. This product is registered under clinical trial identifier NCT03887455. Target conditions include Early Alzheimer's Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03887455Phase 3Active

Competing Products

20 competing products in Early Alzheimer's Disease

See all competitors
ProductCompanyStageHype Score
50 mg PTI-125 + 100 mg PTI-125 + 200 mg PTI-125Cassava SciencesPhase 1
25
Anastrozole + Trastuzumab DeruxtecanDaiichi SankyoPhase 2
52
Fezolinetant + PlaceboAstellas PharmaPhase 2
52
E2609EisaiPhase 1
33
Doxorubicin + Cyclophosphamide + Taxane + Letrozole + Abemaciclib + LHRH AnalogueEli LillyPhase 2
52
PERT-IJS plus trastuzumab, carboplatin and docetaxel + Perjeta plus trastuzumab, carboplatin and docetaxelBioconPhase 3
77
ICGJohnson & JohnsonPre-clinical
23
SHR-A1811 for Injection + Docetaxel injection + Trastuzumab Injection + Carboplatin for Injection + Pertuzumab InjectionJiangsu Hengrui MedicinePhase 3
77
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR7280 tabletsJiangsu Hengrui MedicinePhase 2
52
SHR7280๏ผ›Ganirelix Acetate Injection simulant + SHR7280 simulant๏ผ› Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
77
Nab-paclitaxel in combination with pyrotinibJiangsu Hengrui MedicinePhase 2
52
Adalimumab + Methotrexate + Adalimumab placebo + Methotrexate placeboAbbViePhase 3
77
adalimumab + methotrexateAbbViePhase 3
77
Camizestrant + Tamoxifen + Anastrozole + Letrozole + ExemestaneAstraZenecaPhase 3
77
Camizestrant + Tamoxifen + Anastrozole + Letrozole + Exemestane + AbemaciclibAstraZenecaPhase 3
77
Tamoxifen alone + Tamoxifen + AminoglutethimideAstraZenecaPhase 3
77
Cyclophosphamide + Methotrexate + Fluorouracil implant + Goserelin + TamoxifenAstraZenecaPhase 3
77
Trastuzumab deruxtecan + Standard-of-CareAstraZenecaPhase 2
52
DurvalumabAstraZenecaPhase 2
52

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85